Clinical Research Directory
Browse clinical research sites, groups, and studies.
Coenzyme Q10 in Pediatric Community-Acquired Pneumonia
Sponsor: Tanta University
Summary
The aim of this work is to assess the benefit of coenzyme Q10 supplementation, in addition to standard antibiotic and other supportive therapy, in the management of hospitalized children with community acquired pneumonia
Official title: Coenzyme Q10 as an Adjunct Therapy in Pediatric Community-Acquired Pneumonia
Key Details
Gender
All
Age Range
2 Months - 18 Years
Study Type
INTERVENTIONAL
Enrollment
120
Start Date
2025-12-31
Completion Date
2026-12-31
Last Updated
2026-01-05
Healthy Volunteers
No
Conditions
Interventions
oral coenzymeQ10
60 children with community acquired pneumonia will receive oral coenzymeQ10 in capsule form at a dose of 100-200 mg/kg/day, as adjunct therapy to the usual pneumonia treatment till the recovery of the disease.
Locations (1)
Tanta University
Tanta, Gharbia Governorate, Egypt